Αναζήτηση όρων

Αρχική σελίδα
Philips
EuroPCR 2018

EuroPCR 2018
The World-Leading Course in Interventional
Cardiovascular Medicine

    EuroPCR - Philips - Booth F18 on level 1

    22-25 May 2018 - Palais des Congrès, Paris

    Add to calendar

       

    No silos. No limits.

    When it comes to health, people deserve the best. Yet despite advances, progress is too often slowed. By systems that can’t communicate. By data that gets locked in silos. By clinicians who can’t see the full picture fast enough and patients who feel lost in the system. 

     

    At Philips, we collaborate on designing innovations to seamlessly bring together people, data and technology for personalized, actionable insights. This results in bringing cardiovascular care professionals and their patients together through the integration of data and targeted information across the care continuum. 

     

    We aim to deliver seamless cardiovascular care and improved workflows to reduce variation in the standard of care, and to find the optimal pathways for better clinical outcomes, lower costs, and increased patient and staff satisfaction – that’s health with no bounds.

    Guiding tomorrow's innovation
    Watch the video and see how Philips is removing the bounds of care

    Πληροφορίες επικοινωνίας

    * Αυτό το πεδίο είναι υποχρεωτικό
    *

    Στοιχεία επικοινωνίας

    *
    *
    *

    Στοιχεία Εταιρείας

    *
    *

    Τι σημαίνει αυτό?

    Symposium

    Sponsored by Philips

     

    From SYNTAX II to my daily practice: incorporating state-of-the art techniques to improve clinical outcomes and health economics in complex revascularisation

     

    Wednesday, May 2316.30-18.00, room 252B

    From SYNTAX II to my daily practice: incorporating state-of-the arttechniques to improve clinical outcomes and health economics in complex revascularisation

     

    Wednesday, May 2316.30-18.00, room 252B

    Add to my calendar

    Chairpersons: P.W. Serruys, C. Di Mario

    Panellists: H. Matsuo, M. Patel

    Faculty: A. Banning, J.Escaned, J.Davies, M.Götberg

     

    Attend this session if you want:

    1. To be able to incorporate into your practice the different elements of the SYNTAX II PCI strategy, including the use of physiology and imaging
    2. To appraise the safety of deferral based physiology from DEFINE FLAIR and iFR SWEDEHEART trials
    3. To learn the expected benefits on health economics and patient outcomes derived from incorporating the state-of-the art PCI practices
    Δείτε περισσότεραRead Less

    Training Village program

     

    Please arrive 15 minutes before the start of a session to secure your seat

    Download program

    Join our multiple sessions on:

    • IVUS image interpretation
    • Left Main Complex Case
    • SyncVision co-registration case-based session
    • CTO
    • Devices used for multivessel disease
    • Case-based discussion - Changing treatment from CABG to PCI

    Case Review - Submit your interesting cases and share your experience with peers

     

    In the Cath Lab, clinical expertise, rapid response and team work all play a critical role in determining patient outcomes. We invite you to come together as a clinical community, review challenging or unusual cases, share your knowledge and techniques, and discuss informally the best ways to manage complications with experts.

     

    If you have a complicated or interesting case which offers teaching points for enhancing quality care, please register your case to present it and discuss it with peers and experts at our booth during EuroPCR!

     

    Kindly note that you will be asked to sign an authorization and consent form for your submission as we will not be able to use any case that does not have one.

    case
    Submit your cases

    Join the Cath Lab of the future!

     

     

     

    At this year’s EuroPCR Philips is presenting an exciting new addition to the booth: The cath lab of the future!

     

    A daily program of dedicated interactive sessions on structural heart disease, coronary intervention and vascular intervention will be open to all delegates.

     

    Don’t miss this unique opportunity to stop by the Philips booth F18 on Level 1 and learn how our latest innovations can help you solve your most difficult cases. 

    Cath lab
    Download cathlab of the future schedule

    How do you want to explore Philips Azurion?

     

    At EuroPCR you will be able to visit the Philips Azurion Experience at our booth F18 on level 1.

    Experience Azurion
    Azurion Experience Imac

    Please complete the form below to receive the EuroPCR symposia recording

    Πληροφορίες επικοινωνίας

    * Αυτό το πεδίο είναι υποχρεωτικό
    *

    Στοιχεία επικοινωνίας

    *
    *
    *

    Στοιχεία Εταιρείας

    *
    *

    Τι σημαίνει αυτό?

    Proven outcomes.1,2 Superior value.1,3

     

    Health economic data from the DEFINE FLAIR trial demonstrates an iFR-guided strategy offers reduced costs and improved care compared to an FFR-guided strategy.

    Study result

    Proven outcomes

     
    • Validated in more than 4,500 patients1,2
    • Consistent outcomes as with FFR
    • 0.89 cut-point backed by data1,2,4
    Graphics

    Superior value

     
    • 10% Cost saving per patient
    • 10% reduction in procedure time
    • 90% reduction in patient discomfort1
    Graphic cluster

    1. Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFRand FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017 

    2. Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017

    3. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.  

    4. An iFR cut-point of 0.89 matches best with an FFR ischemic cut-point of 0.80 with a specificity of 87.8% and sensitivity of 73.0%. (From ADVISE II, and iFR Operator’s Manual 505-0101.23)

    FootnotesRead Less

    Explore our solutions and products across the care continuum

    Philips Interventional Hemodynamic system*

    Monitor – Measure – Record

     

    Improving workflow in the interventional lab

    • New user interface designed to simplify hemodynamic monitoring and assessment
    • Improved communication in the lab by visualizing the analysis performed in the control room in the exam room
    • Enhance workflow through integrated iFR** and FFR modality
    • Developed to be confidently used by all staff members with minimal training

    Disclaimer:

    *Not CE marked and not available for sale yet

    **iFR option is considered work in progress and is not CE marked and not available for sale.

    FootnotesRead Less
    hemossystem
    IntelliSpace Cardiovascular empowers our care teams with integrated, comprehensive data within one system that arms them with the relevant actionable data.
    Learn more
    Guiding tomorrow's innovation

    What's trending

    Press inquiries:

     

    For EuroPCR, Press Inquiries, please contact

     

    Fabienne van der Feer

    fabienne.van.der.feer@philips.com

    Twitter: @FC_Feer  

     

    News

    News

    @PhilipsLiveFrom

    Read more

    By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.

    I understand